English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsElectronicsmartindia

    Jump to
    • 'India difficult place for biz, yet confident of progress'

      'India difficult place for biz, yet confident of progress'

      We have been growing twice as fast as the market. We have important products to offer to the Indian healthcare system. We are catching up to some degree in India, says Stefan Oschmann.

    • Post stake buy, GSK may eye acquisition

      Post stake buy, GSK may eye acquisition

      After the UK parent of GlaxoSmithKline Pharmaceutical announced an open offer to increase its stake from 50.3 percent to 75 percent at a cost of Rs 6,400 crore, CNBC-TV18 spoke with an industry veteran, Former Pfizer India MD Kewal Handa to get his views.

    • With Sun Pharma-Merck striking JV, why is SPARC shining?

      With Sun Pharma-Merck striking JV, why is SPARC shining?

      According to CNBC-TV18's research analyst Ekta Batra it's SPARC which has emerged as the winner from this deal between Sun Pharma and Merck. They are targeting a portfolio of around 12 drugs in around 100 countries but the focus is expected to be the top 10 countries which are expected to contribute around 80% of revenues.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347